Chipiron

Supplemental Screening Reconsideration

• 🔥 Ultrasound After DBT Questioned: A 10-year study of 103k exams found supplemental ultrasound after...

A new study of 103k exams finds supplemental ultrasound after negative DBT adds just 1.0 cancer per 1k women while triggering 19 biopsies per detected...

A free Providence risk assessment identifies women with dense breasts or family history who feel healthy yet face elevated breast cancer risk, routing...

Multiparametric MRI shows strong potential for distinguishing luminal from non-luminal invasive ductal carcinoma with an AUC of 0.92, 87% sensitivity...

CEM offers high diagnostic performance at a fraction of MRI's cost in resource-limited settings.

• Diagnostic edge: Sensitivities exceed 90% for...

BRCA1 variants previously linked to breast cancer risk showed no association among Nigerian women in a new case-control study. This demonstrates that...

New breast imaging guidelines push 3D mammography for dense breasts while pulling back on supplemental MRI and ultrasound, leaving radiologists to...

MRI Technology Advances

• 🔥 Siemens MAGNETOM Flow Platform: Siemens introduced the MAGNETOM Flow 1.5T helium-free MRI platform with AI-powered...

GE HealthCare's ten-year, $500M Care Alliance with Catholic Health will install over 1,300 pieces of equipment—including AI-powered MR, CT, PET, and...

Institutional clashes over breast screening guidelines highlight who should decide: radiology groups push annual mammograms from age 40, while ACP and...

Northern Light Health’s mobile mammography unit has completed more than 1,100 screenings across 12 rural locations since April 2024, using the same...

ATM PV/PPV heterozygotes face a fourfold increased breast cancer risk (HR 4.0), reaching 40% cumulative risk by age 80, supporting enhanced high-risk protocols including annual MRI eligibility.

Siemens Healthineers' MAGNETOM Flow Platform delivers helium-independent 1.5T MRI with sealed-for-life design using only 0.7L helium and DryCool...

ASCO's updated guidelines introduce risk-adapted surveillance for breast cancer survivors, aiming to align follow-up intensity with recurrence risk,...

A patient-level partitioning scheme before augmentation, paired with a lightweight Inter-View Attention Fusion module on ResNet50, delivers 97.12% accuracy and 0.9876 AUC-ROC on CBIS-DDSM while preventing data leakage across 222 patients.

• BPE on MRI may capture breast cancer risk missed by density alone, particularly in Black women.
• After adjustments, Black women showed 31% higher...

High-Risk Screening Guidelines

• 🔥 ERN GENTURIS Guideline: New ERN GENTURIS guideline explicitly recommends breast MRI surveillance for PTEN...

AI tools promoted to close health inequities may instead widen them if development stays concentrated in high-income countries with lower disease...

ERN GENTURIS has published a dedicated cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS). The recommendations address surveillance needs in this high-risk genetic population.

In the DBT era, screening ultrasound after negative exams yields 1 additional cancer per 1000 at a 98.5% false-positive rate.

• 94.8% of resulting...